Form 4 for ALT Altimmune, Inc.
Accepted 2025-08-04 00:00:00 ET · period of report 2025-07-31 · accession 0001104659-25-073624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-04 | 2025-07-31 | ALT | Roberts M Scot | CSO | A - Grant | $3.14 | +846 | 74.1K | +1% | +$2,656 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2025-07-31 | A | A | 846 | $3.14 | 74,066 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2025. |